Filter by: Subject

Filter by: Subject

Results Per Page:

Mycobacterium tuberculosis (MTB) (29)
Tuberculosis (TB) (13)
Drug resistance (7)
South Africa (SA) (6)
Bedaquiline (5)
Drug susceptibility testing (DST) (3)
Clofazimine (2)
Clofazimine (CFZ) (2)
Drug-resistant tuberculosis (DR-TB) (2)
Ethiopia (2)
Linezolid (2)
Meta-analysis (2)
Minimum inhibitory concentrations (MIC) (2)
Multidrug-resistant (MDR) (2)
Multidrug-resistant tuberculosis (MDR-TB) (2)
Next generation sequencing (NGS) (2)
Pyrazinamide (2)
Pyrazinamide (PZA) (2)
Pyrazinamide resistance (2)
960™ (1)
Abbott RealTime MTB (1)
Acquired drug resistance (1)
Acquired immune deficiency syndrome (AIDS) (1)
Aerosol particles (1)
Africa (1)
Anti-inflammatory activity (1)
Antibiotic resistance (1)
Antibiotic-resistant (1)
Antimicrobial resistance (AMR) (1)
Antimicrobials (1)
Antimycobacterial (1)
Antimycobacterials (1)
Antitubercular drugs (1)
Antituberculosis therapy (1)
Assays (1)
AtpE mutations (1)
Attributable risk (1)
Autophagy (1)
Bacteria (1)
Bacterial sub-populations (1)
Bias analysis (1)
Biofilm formation (1)
Biotechnology (1)
Canonical variant (1)
Cigarette smoke (1)
Cigarette smoke condensate (CSC) (1)
Critical concentration (CC) (1)
Diagnostics (1)
Diarylquinolines (1)
Drug-resistance (1)
Drug-resistant tuberculosis (1)
Drug-resistant tuberculosis (DRTB) (1)
Drug-susceptibility testing (1)
Drugs (1)
Early bactericidal activity (1)
Epidemics (1)
Epidemiology (1)
Ethambutol (EMB) (1)
Ethanol-killed MTB (EK-MTB) (1)
Extensively drug-resistant (XDR) (1)
Extensively drug-resistant tuberculosis (XDR-TB) (1)
External quality assessment (EQA) (1)
Extrapulmonary tuberculosis (EPTB) (1)
F1/F0-ATPase (1)
Fluoroquinolone (1)
Fluoroquinolones (FLQ) (1)
Gene mutation (1)
Genetic signatures (1)
GenoType MTBDRsl version 2.0 (1)
Genotypic analyses (1)
Growth (1)
HIV/AIDS (1)
Human immunodeficiency virus (HIV) (1)
Immunology (1)
In vitro (1)
In vitro model (1)
In vitro mutants (1)
Infectious diseases (1)
IS6110 (1)
Isoniazid (INH) (1)
Kanamycin (KAN) (1)
KwaZulu-Natal (KZN) (1)
Line probe assay (LPA) (1)
Line-probe assay (1)
Lung–gut microbiota axis (1)
MAB binding activity (1)
MDR-TB (1)
Metagenomics (1)
Metatranscriptomics (1)
MGIT 960 system (1)
MGIT™ (1)
Microbiology (1)
Microbiome (1)
Minimal inhibitory concentration (MIC) (1)
Minimum inhibitory concentration (1)
Missing data (1)
Molecular biology (1)
Molecular diagnostic testing (1)
Molecular epidemiology (1)
Monoclonal antibodies (MABs) (1)